Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model

Cancer Gene Therapy

Volumn 16, Issue 5, 2009, Pages 423-429

  Li, Z ^a   Xiang, J ^a   Zhang, W ^a   Fan, S ^b   Wu, M ^a   Li, X ^a   Li, G ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Chemotherapy; NM23 H1 gene; Poly L lysine modified iron oxide nanoparticles; Tumor metastasis

Indexed keywords

CYCLOPHOSPHAMIDE; GREEN FLUORESCENT PROTEIN; IRON OXIDE; NANOPARTICLE; NUCLEOSIDE DIPHOSPHATE KINASE A; PLASMID DNA; POLYLYSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER GROWTH; CONTROLLED STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, INBRED C57BL; NANOPARTICLES; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; ZEBRAFISH PROTEINS;

EID: 65049085057     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2008.97     Document Type: Article

References (47)

1. Gardlik R, Pálffy R, Hodosy J, Lukács J, Turna J, Celec P. Vectors and delivery systems in gene therapy. Med Sci Manit 2005;11:110-121.
2. Wu Q, Moyana T, Xiang J. Cancer gene therapy by adenovirus-mediated gene transfer. Curr Gene Ther 2001; 1: 101-122.
3. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol 2003; 21: 117-122.
4. Lundstrom K, Boulikas T. Viral and non-viral vectors in gene therapy: technology development and clinical trials. Technol Cancer Res Treat 2003; 2: 471-486.
5. Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 2002; 54: 715-758.
6. Matsuura M, Yamazaki Y, Suqiyama M, Kondo M, Ori H, Nango M et al. Polycation liposome-mediated gene transfer in vivo. Biochim Biophys Acta 2003; 1612: 136-143.
7. Kushibikil T, Matsumoto K, Nakamura T, Tabata Y. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Therapy 2004; 11: 1205-1214.
8. Ogris M. Non-viral cancer gene therapy-what is best? Drug Discovery Today 2003; 8: 63.
9. Gaseo MR, Gaseo P. Nanovector. Nanomedicine 2007; 2: 955-960.
10. Ferrari M. Nanovector therapeutics. Curr Opin Chem Biol 2005; 9: 343-346.
11. Li Z, Zhu SG, Gan K, Zhang Q, Zeng Z, Zhou Y et al. Poly-Llysine-modified silica nanoparticles: a potential oral gene delivery system. J Nanoscience and Nanotechnology 2005; 5: 1199-1203.
12. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat rev Cancer 2005; 5: 161-171.
13. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003; 2: 347-360.
14. Santhakumaran LM, Thomas T, Thomas TJ. Enhanced cellular uptake of triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers. Nucleic Acids Res 2004; 32: 2102-2112.
15. Zhu SG, Lu HB, Xiang JJ, Tang K, Zhang BC, Zhou M, et al. A novel nonviral nanoparticle gene vector: poly-Llysine silica nanoparticles. Chin Sci Bull 2002; 47: 654-657.
16. Zhu SG, Xiang JJ, Li XL, Shen SR, Lu HB, Zhou J et al. Poly(L-lysine)-modified silica nanoparticles for delivery of antisence oligonucleotides. Biotechnol Appl Biochem 2004; 39: 179-187.
17. Xiang JJ, Zhu SG, Lu HB, Ruan JM, Zhang BC, Li J et al. Use of Magnetic iron oxide nanoparticles as gene carrier. Chinese Journal of cancer 2001; 10: 1009-1014.
18. Xiang JJ, Tang JQ, Zhu SG, Nie XM, Lu HB, Shen SR et al. IONP-PLL: a novel non-viral vector for efficient gene delivery. J Gene Medicine 2003; 5: 803-817.
19. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA et al. Evidence for a novel gene associated with low tumor metastatic potential, J Natl Cancer Inst 1988; 80: 200-204.
20. Sgouros J, Galani E, Gonos E, Moutsatsou P, Belechri M, Skarlos D et al. Correlation of NM23-H1 gene expression with clinical outcome in patients with advanced breast cancer. In Vivo 2007; 21: 519-522.
21. Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG et al. NM23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Cancer Res 2007; 67: 11751-11759.
22. Boissan M, Wendum D, Arnaud-Dabernat S, Munier A, Debray M, Lascu I et al. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst 2005; 97: 836-845.
23. Che G, Chen J, Liu L, Wang Y, Li L, Qin Y et al. Transfection of NM23-H1 increased expression of betaCatenin, E-Cadherin and TIMP-I and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981. Neoplasma 2006; 53: 530-537.
24. Prowatke I, Devens F, Benner A, Gröne EF, Mertens D, Gröne HJ et al. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. Br J Cancer 2007; 96: 82-88.
25. Ferenc T, Lewinski A, Lange D, Niewiadomska H, Sygut J, Sporny S et al. Analysis of NM23-H1 protein immunor eactivity in follicular thyroid tumors. Pol J Pathol 2004; 55: 149-153.
26. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM et al. Evidence for Nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993; 8: 855-865.
27. Pavelic K, Kapitanovic S, Radosevic S, Bura M, Seiwerth S, Pavelias LJ et al. Increased activity of NM23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis. Mol Med 2000; 78:111-118.
28. Fishbach M, Settleman J. Specific biochemical inactivation of oncogenic ras proteins by nucleoside diphosphate kinase. Cancer Res 2003; 63: 40894094.
29. Engel M, Veron M, Theisinger B, Lacombe ML, Seib T, Dooley S et al. A novel serine/threonine-specific protein phosphotransferase activity of Nm23/nucleosidediphosphate kinase. Eur J Biochem 1995; 234: 200-207.
30. Lombardi D, Mileo AM. Protein interactions provide new insight into Nm23/nucleoside diphosphate kinase functions. J Bioenerg Biomembr 2003; 5: 67-71.
31. Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem 2005; 386: 193-205.
32. Salerno M, Palmieri D, Bouadis A, Halverson D, Steeg PS. NM23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras 1 (KSRl) Erk scaffold in breast carcinoma cells. Mol Cell Biol 2005; 25: 1379-1388.
33. Hartsough MT, Morrison DK, Salerno M, Palmieri D, Quatas T, Mair M et al. NM23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 2002; 277: 32389-32399.
34. Jung HY, Seong HA, Ha HJ. NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function. J Biol Cem 2007; 282: 35293-35307.
35. Xiang JJ, Nie XM, Tang JQ, Wang YJ, Li Z, Gan K et al. In vitro gene transfection by magnetic iron oxide nanoparticles and the effect of magnetic field on the efficiency of transfection. Zhonghua Zhong Liu Za Zhi 2004; 26: 71-74.
36. Lee H, Lee E, Kim do K, Jang NK, Jeong YY, Jon S. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc 2006; 128: 7383-7389.
37. Hanessian S, Grzyb JA, Cengelli F, Juillerat-Jeanneret L. Synthesis of chemically functionalized superparamagnetic nanoparticles as delivery vectors for chemotherapeutic drugs. Bioorg Med Chem 2008; 16: 2921-2931.
38. Pan BF, Cui DX, Sheng Y, Ozkan C, Gao F, He R et al. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 2007; 67: 8156-8163.
39. Safarik I, Safarikova M. Magnetic techniques for the isolation and purification of proteins and peptides. Biomagn Res Technol 2004; 2: 7.
40. Chemla YR, Grossman HL, Poon Y, McDermott R, Stevens R, Alper MD et al. Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc Natl Acad Sci USA 2000; 97: 14268-14272.
41. Kim DH, Lee SH, Kim KN, Kim KM, Chim IB, Lee YK. Cytotoxicity of ferrite particles by MTT and agar diffusion methods for hyperthermic application. J Magn Magn Mater 2005; 293: 287-292.
42. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003; 100: 13549-13554.
43. Gao L, Zhuang J, Nie L, Zhang J, Zhang Y, Gu N et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat Nanotechnol 2007; 2: 577-583.
44. Morishita N, Nakagami H, Morishita R, Takeda S, Mishima F, Terazono B et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun 2005; 334: 1121-1126.
45. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007; 2: 23-39.
46. Sonabend AM, Velicu S, Ulasov IV, Han Y, Tyler B, Breni H et al. A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma. Anticancer Drugs 2008; 19: 133-142.
47. He C, He P, Zhu YS. Expression of NM23-H1-GFP fusion protein in human lung cancer cells and its effect on in vitro invasive potential of tumor cells. Chin J Biochem Mol Biol 2000; 16: 51-56.